Skip to main content
. 2023 Dec 2;15:100419. doi: 10.1016/j.jvacx.2023.100419

Fig. 3.

Fig. 3

Observed/Expected analyses for selected AESIs with mRNA vaccination through July 31, 2022, in children aged five to 11 years of age with two distinct risk period definitions. All cases in the ‘Day 0 to Day 21′ analyses are also included in the ‘Day 0 to Day 42′ analyses.